Amphetamines are common in drug abuse, particularly in the young population. These sympathomimetic amines work by activating the sympathetic nervous system. As a result, the heart rate increases and the oxygen supply decreases, causing the oxygen demand of the heart to increase. However, the most common cardiovascular effects are tachycardia and hypertension. Acute myocardial infarction (AMI) is reported rarely after the use of amphetamines, especially in young patients \[[@ref1]\]. We report a case of a healthy, young man who presented to our emergency department after oral consumption of amphetamines. In this case, amphetamine abuse caused myocardial ischaemia due to blood clot formation.

A 21-year-old university student was brought by his teacher to the emergency department with severe chest pain and palpitation for 2 h. He was of average build with no history of similar symptoms, such as ischaemic heart disease, diabetes mellitus, hypertension, dyslipidaemia, or atrial fibrillation. He had no family history of similar symptoms or coronary artery disease. He was not on any medication. He had no allergies and no history of smoking or drinking alcohol. The patient used amphetamine tablets occasionally for recreational purpose and reported last taking an amphetamine tablet about 7 h before the presentation. At the time of arrival to the emergency room, his blood pressure was 95/60 mm Hg, heart rate was 130 beats per minute, respiratory was 18 breaths per minute, oral temperature was 37.5°C, and oxygen saturation was 98% in room air. Generally, he appeared with agitation and severe chest discomfort. His ECG demonstrated atrial fibrillation with marked ST segment elevation at augmented unipolar right arm lead (aVR) and diffuse ST segment depression at the residual leads. Echocardiogram showed poor left ventricle ejection fraction (LV EF) 30% with global hypokinesia and mild mitral regurgitation. Other laboratory assessment revealed evidence of myocardial injury, with positive troponin I. Coronary angiography showed a total occlusion of the left main (LM) artery ([Figure 1](#F1){ref-type="fig"}) but normal right coronary artery (RCA) ([Figure 2](#F2){ref-type="fig"}). Percutaneous coronary intervention was selected as the treatment strategy according to the patient's decision. An intra-aortic balloon pump (IABP) was inserted via the left groin.
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![Initial coronary angiogram of right coronary artery (left caudal view)](AMS-AD-5-40685-g002){#F2}

The LM artery was engaged with a 7 Fr Launcher EBU 3.5 guiding catheter (Medtronic, Minnesota, USA) via the right groin. The distal part of the LCX was wired with pilot 50 wires (Abbott Vascular, SantaClara, CA, USA). The LM clot was aspirated using an Export aspiration catheter (Medtronic, Minnesota, USA) and ballooned at the proximal part of the LCX with Minitrek (Abbott Vascular, SantaClara, CA, USA) 2.5 × 15 mm. The left anterior descending (LAD) artery was wired with a Miracle 6 wire (Asahi Intecc Co. Ltd, Aichi, Japan). There was a residual clot at the LM-LCX after multiple clot aspiration ([Figure 3](#F3){ref-type="fig"}). The clot was re-aspirated ([Figure 4](#F4){ref-type="fig"}) and the bifurcated distal LM was stented by Double Kissing Crush stenting technique (DK CRUSH), step by step: 1) balloon NC trek (Abbott Vascular, Santa Clara, CA, USA) 2.5 × 15 mm in LM-LAD and Firebird 2 drug-eluting stent (DES) (MicroPort, Shanghai, China) was introduced into the LCX; 2) then the balloon in the LM-LAD was inflated to crush the deployed LCX stent; 3) after rewiring LCX proximally, first kissing was performed; 4) stenting LM-LAD with a 4.0 × 13 mm Firebird 2 drug-eluting stent (DES); and 5) the final kissing balloon inflation was conducted after rewiring the LCX from the proximal LM-LAD stent cell. After stenting, a proximal optimisation technique was performed with NC balloon trek (Abbott Vascular, SantaClara, CA, USA) 4.0 × 8 mm to improve the stent strut apposition. The result of the procedure was excellent with thrombolysis in myocardial infarction (TIMI) flow (TIMI-3) achieved in all branches ([Figures 5, 6](#F5){ref-type="fig"}). No immediate complication occurred. A future plan and multidisciplinary team follow-up with psychiatric consultation was set before discharging the patient home. He was discharged from the hospital after one week with stable condition.

![Residual clot at left main-left circumflex artery after clot was aspirated (right caudal view)](AMS-AD-5-40685-g003){#F3}

![Angiogram before stent implantation (right cranial view)](AMS-AD-5-40685-g004){#F4}

![Good thrombolysis in myocardial infarction flow all branches after stenting (left caudal view)](AMS-AD-5-40685-g005){#F5}

![Good thrombolysis in myocardial infarction flow all branches after stenting (left cranial view)](AMS-AD-5-40685-g006){#F6}

Amphetamines are potent sympathomimetic agents. The primary mechanism of action is blockage of the presynaptic reuptake of catecholamines and enhanced sympathetic stimulation; the most common cardiovascular side effects are a rise in pulse and blood pressure \[[@ref2]\]. Other common complaints can be chest pain and shortness of breath. The cardiovascular effects of amphetamines include a strong association with AMI \[[@ref3], [@ref4]\], probably related to catecholamine surge, coronary vasospasm, and coronary thrombosis. Additionally, the chronic use of amphetamines is described to promote coronary atherosclerosis \[[@ref5]\]. Amphetamines induce endothelial tissue factor expression and impair tissue factor pathway inhibitor. They also increase expression of plasminogen activator inhibitor-1 (PAI-1), a key fibrinolysis suppressant in human vascular endothelial cells \[[@ref3], [@ref6]\]. Moreover, amphetamines are known to increase platelet aggregation and trigger atherosclerotic plaque rupture \[[@ref2], [@ref6]\]. This patient's original severe left ventricular systolic dysfunction and generalised wall motion abnormality might be due to AMI; however, amphetamine is reported to induce acute cardiomyopathy \[[@ref7], [@ref8]\]. To our knowledge, there are no publications of amphetamine-induced acute myocardial infarction with total occlusion of the left main artery. By contrast, cases with abnormalities in the LAD artery \[[@ref1], [@ref7]\], right coronary artery (RCA) \[[@ref9]\], or left circumflex artery (LCx) alone \[[@ref4]\], due to amphetamine use, have been reported. Moreover, the mechanism of drug-induced MI is usually associated with coronary spasms \[[@ref5], [@ref10], [@ref11]\]. The lack of vasospasms and the presence of thrombosis in our case ([Figure 7](#F7){ref-type="fig"}) are unusual in literature.

![Clots retrieved from coronary artery](AMS-AD-5-40685-g007){#F7}

Amphetamine-associated AMI may occur more commonly in the acute care setting if the rate of amphetamine abuse continues to increase. We find this case of amphetamine-induced AMI to be of particular interest for understanding the range of possible cardiovascular issues we may encounter in our emergency room, because early diagnosis and prompt treatment can be the key to successful management of this potentially fatal complication.

In conclusion, this case of amphetamine-induced AMI, with total LM thrombosis, is a good example for understanding the range of possible drug-induced cardiovascular manifestations and how to manage a difficult life-threatening situation. Despite young age, significant thrombus burden may be present. In patients with typical electrocardiogram (ECG) changes and elevated troponin levels, coronary angiography is indicated in this population.
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